Literature DB >> 26537584

MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.

Qian Jiang1, Miao He1, Shu Guan2, Mengtao Ma1, Huizhe Wu1, Zhaojin Yu1, Longyang Jiang1, Yan Wang1, Xingyue Zong1, Feng Jin2, Minjie Wei3.   

Abstract

Wnt/β-catenin signaling pathway plays a major role in the cancer metastasis. Several microRNAs (miRNAs) are contributed to the inhibition of breast cancer metastasis. Here, we attempted to find novel targets and mechanisms of microRNA-100 (miR-100) in regulating the migration and invasion of breast cancer cells. In this study, we found that miR-100 expression was downregulated in human breast cancer tissues and cell lines. The overexpression of miR-100 inhibited the migration and invasion of MDA-MB-231 breast cancer cells. Inversely, the downregulation of miR-100 increased the migration and invasion of MCF-7 breast cancer cells. Furthermore, FZD-8, a receptor of Wnt/β-catenin signaling pathway, was demonstrated a direct target of miR-100. The overexpression of miR-100 decreased the expression levels not only FZD-8 but also the key components of Wnt/β-catenin pathway, including β-catenin, metalloproteniase-7 (MMP-7), T-cell factor-4 (TCF-4), and lymphoid enhancing factor-1 (LEF-1), and increased the protein expression levels of GSK-3β and p-GSK-3β in MDA-MB-231 cells, and the transfection of miR-100 inhibitor in MCF-7 cells showed the opposite effects. In addition, the expression of miR-100 was negatively correlated with the FZD-8 expression in human breast cancer tissues. Overall, these findings suggest that miR-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway and manipulation of miR-100 may provide a promoting therapeutic strategy for cancer breast treatment.

Entities:  

Keywords:  Breast cancer; FZD-8; Invasion; MiR-100; Migration; Wnt/β-catenin signaling pathway

Mesh:

Substances:

Year:  2015        PMID: 26537584     DOI: 10.1007/s13277-015-4342-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  29 in total

Review 1.  The Wnt/β-catenin pathway in ovarian cancer: a review.

Authors:  Rebecca C Arend; Angelina I Londoño-Joshi; J Michael Straughn; Donald J Buchsbaum
Journal:  Gynecol Oncol       Date:  2013-10-11       Impact factor: 5.482

2.  β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis.

Authors:  F Klemm; A Bleckmann; L Siam; H N Chuang; E Rietkötter; D Behme; M Schulz; M Schaffrinski; S Schindler; L Trümper; F Kramer; T Beissbarth; C Stadelmann; C Binder; T Pukrop
Journal:  Carcinogenesis       Date:  2010-12-20       Impact factor: 4.944

3.  Ancient animal microRNAs and the evolution of tissue identity.

Authors:  Foteini Christodoulou; Florian Raible; Raju Tomer; Oleg Simakov; Kalliopi Trachana; Sebastian Klaus; Heidi Snyman; Gregory J Hannon; Peer Bork; Detlev Arendt
Journal:  Nature       Date:  2010-01-31       Impact factor: 49.962

4.  miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer.

Authors:  Peng Liu; Hailin Tang; Bo Chen; Zhimin He; Min Deng; Minqing Wu; Xiaoping Liu; Lu Yang; Feng Ye; Xiaoming Xie
Journal:  Cancer Lett       Date:  2014-11-27       Impact factor: 8.679

5.  Tumor-initiating cells and FZD8 play a major role in drug resistance in triple-negative breast cancer.

Authors:  Shuping Yin; Liping Xu; R Daniel Bonfil; Sanjeev Banerjee; Fazlul H Sarkar; Seema Sethi; Kaladhar B Reddy
Journal:  Mol Cancer Ther       Date:  2013-02-27       Impact factor: 6.261

6.  MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2).

Authors:  Meng-Tao Ma; Miao He; Yan Wang; Xu-Yang Jiao; Lin Zhao; Xue-Feng Bai; Zhao-Jin Yu; Hui-Zhe Wu; Ming-Li Sun; Zhi-Guo Song; Min-Jie Wei
Journal:  Cancer Lett       Date:  2013-07-20       Impact factor: 8.679

7.  miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling.

Authors:  C A Gebeshuber; J Martinez
Journal:  Oncogene       Date:  2012-08-27       Impact factor: 9.867

8.  MiR-29b downregulates canonical Wnt signaling by suppressing coactivators of β-catenin in human colorectal cancer cells.

Authors:  Maitreyi Subramanian; Srinivasa R Rao; Pooja Thacker; Suvro Chatterjee; Devarajan Karunagaran
Journal:  J Cell Biochem       Date:  2014-11       Impact factor: 4.429

9.  MicroRNA-100 regulates pancreatic cancer cells growth and sensitivity to chemotherapy through targeting FGFR3.

Authors:  Zhipeng Li; Xu Li; Chao Yu; Min Wang; Feng Peng; Jie Xiao; Rui Tian; Jianxin Jiang; Chengyi Sun
Journal:  Tumour Biol       Date:  2014-10-26

10.  Clinicopathological significance and prognostic value of DNA methyltransferase 1, 3a, and 3b expressions in sporadic epithelial ovarian cancer.

Authors:  Xuefeng Bai; Zhiguo Song; Yingzi Fu; Zhaojin Yu; Lin Zhao; Haishan Zhao; Weifan Yao; Desheng Huang; Xiaoyi Mi; Enhua Wang; Zhihong Zheng; Minjie Wei
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

View more
  36 in total

1.  Emerging roles of circRNA_NEK6 targeting miR-370-3p in the proliferation and invasion of thyroid cancer via Wnt signaling pathway.

Authors:  Fukun Chen; Zhiping Feng; Jialun Zhu; Pengjie Liu; Chuanzhou Yang; Rongkai Huang; Zhiyong Deng
Journal:  Cancer Biol Ther       Date:  2018-09-12       Impact factor: 4.742

Review 2.  Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer.

Authors:  Nijiro Nohata; Yusuke Goto; J Silvio Gutkind
Journal:  J Hum Genet       Date:  2016-10-13       Impact factor: 3.172

3.  MicroRNA-100 suppresses human gastric cancer cell proliferation by targeting CXCR7.

Authors:  Yongfeng Cao; Jiaye Song; Jianjuan Ge; Zhuchen Song; Jia Chen; Changping Wu
Journal:  Oncol Lett       Date:  2017-10-31       Impact factor: 2.967

Review 4.  The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma.

Authors:  Keiichi Koshizuka; Toyoyuki Hanazawa; Ichiro Fukumoto; Naoko Kikkawa; Yoshitaka Okamoto; Naohiko Seki
Journal:  J Hum Genet       Date:  2016-08-25       Impact factor: 3.172

Review 5.  Regulation of epithelial-mesenchymal transition through microRNAs: clinical and biological significance of microRNAs in breast cancer.

Authors:  Fu Peng; Liang Xiong; Hailin Tang; Cheng Peng; Jianping Chen
Journal:  Tumour Biol       Date:  2016-09-19

Review 6.  Wnt signaling in triple-negative breast cancer.

Authors:  Sö-G Pohl; N Brook; M Agostino; F Arfuso; A P Kumar; A Dharmarajan
Journal:  Oncogenesis       Date:  2017-04-03       Impact factor: 7.485

7.  MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.

Authors:  Saber Imani; Chunli Wei; Jingliang Cheng; Md Asaduzzaman Khan; Shangyi Fu; Luquan Yang; Mousumi Tania; Xianqin Zhang; Xiuli Xiao; Xianning Zhang; Junjiang Fu
Journal:  Oncotarget       Date:  2017-03-28

Review 8.  Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells.

Authors:  James A McCubrey; Timothy L Fitzgerald; Li V Yang; Kvin Lertpiriyapong; Linda S Steelman; Stephen L Abrams; Giuseppe Montalto; Melchiorre Cervello; Luca M Neri; Lucio Cocco; Alberto M Martelli; Piotr Laidler; Joanna Dulińska-Litewka; Dariusz Rakus; Agnieszka Gizak; Ferdinando Nicoletti; Luca Falzone; Saverio Candido; Massimo Libra
Journal:  Oncotarget       Date:  2017-02-21

Review 9.  The crosstalk between microRNAs and the Wnt/β-catenin signaling pathway in cancer.

Authors:  Yin Peng; Xiaojing Zhang; Xianling Feng; Xinmim Fan; Zhe Jin
Journal:  Oncotarget       Date:  2017-02-21

10.  Frizzled 8 promotes the cell proliferation and metastasis of renal cell carcinoma.

Authors:  Qiwei Yang; Ye Wang; Xiuwu Pan; Jianqing Ye; Sishun Gan; Fajun Qu; Lu Chen; Chuanmin Chu; Yi Gao; Xingang Cui
Journal:  Oncotarget       Date:  2017-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.